￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Introduction and marketing status of Sunvozertinib

2026-02-01 22:25:32

Check Details
Related introduction of Linvoseltamab: What kind of medicine is it used to treat?

2026-02-01 22:25:32

Check Details
Oral ritxitinib combined with nbUV-B accelerates pigmentation in patients with non-segmental vitiligo

2026-02-01 22:25:32

Check Details
Comparison of the pharmacological effects of sparsentan/sparsentan and irbesartan

2026-02-01 22:25:32

Check Details
Does ixazomib need to be taken long-term to maintain the therapeutic effect?

2026-02-01 22:25:32

Check Details
Rubicatin/Rubitidine medical insurance reimbursement policy and ratio

2026-02-01 22:25:32

Check Details
Detailed instructions and instructions for use of pirfenidone

2026-02-01 22:25:32

Check Details
Linvoseltamab (rivosettamab) instruction manual in Chinese

2026-02-01 22:25:32

Check Details
Canafenib/encofenib combination approved in China in BRAF V600E+ metastatic colorectal cancer

2026-02-01 22:25:32

Check Details
What is the effect of taking ritexitinib for three years?

2026-02-01 22:25:32

Check Details
The latest marketing progress and trends of sparsentan/sparsentan in 2025

2026-02-01 22:25:32

Check Details
How many boxes of ixazomib are usually needed for a complete course of treatment?

2026-02-01 22:25:32

Check Details
Category
相关知识